Oligodendroglioma secondary prevention

Revision as of 14:45, 27 November 2017 by Mmir (talk | contribs) (Mahshid)
Jump to navigation Jump to search

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma secondary prevention

CDC on Oligodendroglioma secondary prevention

Oligodendroglioma secondary prevention in the news

Blogs on Oligodendroglioma secondary prevention

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

There are no secondary preventive measures available for oligodendroglioma.

Secondary Prevention

There are no secondary preventive measures available for oligodendroglioma.

References


Template:WikiDoc Sources